Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. has demonstrated a sequential increase in commercial pricing of 2.2%, reflecting a stable pricing environment that supports revenue growth. The company's Industrial Injury Prevention (IIP) segment reported a notable revenue increase of 22.2% overall, with an 18.4% increase when excluding contributions from mergers and acquisitions, indicating strong organic growth in this area. Additionally, the recent acquisition of the Metro business has resulted in an improved net rate of $107.50, up from $101, which suggests enhanced profitability potential for the company moving forward.

Bears say

US Physical Therapy has experienced a decline of 0.6% in a key financial metric, dropping from $84.46 to $83.95 year-over-year, indicating a potential trend of stagnation or decline in its revenue growth. The company has also faced ongoing reimbursement cuts over the past five years, amounting to a significant $20 million headwind to profitability, which could severely impact its financial health. Additionally, the ratio of rent, clinic, and other expenses to revenue increased to 20.2%, slightly above estimates, raising concerns about cost management amid these revenue challenges.

USPH has been analyzed by 3 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 3 analysts, USPH has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.